The efficacy of combination therapy of toltrodine and tamsulosin on urinary symptoms
Phase 3
Completed
- Conditions
- rinary symptoms caused by stent.
- Registration Number
- IRCT20190119042410N1
- Lead Sponsor
- Boushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Patients over 18 years of age
Completion of written consent form
One-way ureteral stenting after ureteroscopy and TUL for ureteral stones
Negative urine culture prior to TUL and stents
male
Exclusion Criteria
Physician diagnosed sensitivity to tamsulosin, toltrodine or folic acid
Establishment of ureteral stent during the last 6 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score from the USSQ Questionnaire. Timepoint: Start studying and two weeks later. Method of measurement: USSQ Questionnaire.
- Secondary Outcome Measures
Name Time Method